Jamie L. Jordan

Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2 + Breast Cancer

Yazan Alwarawrah, Philip F. Hughes, David R. Loiselle et al. · Cell chemical biology · 2016 · 158 citations · Full text

Medicine, Oncology, Pharmacology +8

Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models

Gina Song, David B. Darr, Charlene Santos et al. · Clinical Cancer Research · 2014 · 94 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Identification of an Allosteric Small-Molecule Inhibitor Selective for the Inducible Form of Heat Shock Protein 70

Matthew K. Howe, Khaldon Bodoor, David A. Carlson et al. · Chemistry & Biology · 2014 · 69 citations

Pharmacy, Biochemistry, Medicinal Chemistry +13

Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors

John Bisi, Jessica A. Sorrentino, Jamie L. Jordan et al. · Oncotarget · 2017 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma

Craig C. Carson, Stergios J. Moschos, Sharon N. Edmiston et al. · Clinical Cancer Research · 2015 · 18 citations · Full text

Medicine, Cancer Biology, Oncology +15